Postoperative radiotherapy in the treatment of single metastases to the brain - A randomized trial

被引:1371
作者
Patchell, RA
Tibbs, PA
Regine, WF
Dempsey, RJ
Mohiuddin, M
Kryscio, RJ
Markesbery, WR
Foon, KA
Young, B
机构
[1] Univ Kentucky, Med Ctr, Dept Neurosurg, Div Neurosurg, Lexington, KY 40536 USA
[2] Univ Kentucky, Med Ctr, Dept Neurol, Lexington, KY 40536 USA
[3] Univ Kentucky, Med Ctr, Dept Radiat Med, Lexington, KY 40536 USA
[4] Univ Kentucky, Med Ctr, Dept Stat, Lexington, KY 40536 USA
[5] Univ Kentucky, Med Ctr, Dept Internal Med, Lexington, KY 40536 USA
[6] Univ Kentucky, Med Ctr, Dept Pathol, Lexington, KY 40536 USA
[7] Univ Wisconsin, Sch Med, Dept Neurol Surg, Madison, WI USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1998年 / 280卷 / 17期
关键词
D O I
10.1001/jama.280.17.1485
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context.-For the treatment of a single metastasis to the brain, surgical resection combined with postoperative radiotherapy is more effective than treatment with radiotherapy alone. However, the efficacy of postoperative radiotherapy after complete surgical resection has not been established. Objective.-To determine if postoperative radiotherapy resulted in improved neurologic control of disease and increased survival, Design,-Multicenter, randomized, parallel group trial. Setting.-University-affiliated cancer treatment facilities. Patients.-Ninety-five patients who had single metastases to the brain that were treated with complete surgical resections (as verified by postoperative magnetic resonance imaging) between September 1989 and November 1997 were entered into the study. Interventions.-Patients were randomly assigned to treatment with postoperative whole-brain radiotherapy (radiotherapy group, 49 patients) or no further treatment (observation group, 46 patients) for the brain metastasis, with median followup of 48 weeks and 43 weeks, respectively, Main Outcome Measures.-The primary end point was recurrence of tumor in the brain; secondary end points were length of survival, cause of death, and preservation of ability to function independently. Results.-Recurrence of tumor anywhere in the brain was less frequent in the radiotherapy group than in the observation group (9 [18%] of 49 vs 32 [70%] of 46; P<.001). Postoperative radiotherapy prevented brain recurrence at the site of the original metastasis (5 [10%] of 49 vs 21 [46%] of 46; P<.001) and at other sites in the brain (7 [14%] of 49 vs 17 [37] of 46; P<.01), Patients in the radiotherapy group were less likely to die of neurologic causes than patients in the observation group (6 [14%] of 43 who;died vs 17 [44%] of 39; P=.003), There was no significant difference between the 2 groups in overall length of survival or the length of time that patients remained functionally independent. Conclusions.-Patients with cancer and single metastases to the brain who receive treatment with surgical resection and postoperative radiotherapy have fewer recurrences of cancer in the brain and are less likely to die of neurologic causes than similar patients treated with surgical resection alone.
引用
收藏
页码:1485 / 1489
页数:5
相关论文
共 24 条
  • [21] SZE G, 1990, AM J NEURORADIOL, V11, P785
  • [22] TREATMENT OF SINGLE BRAIN METASTASIS - RADIOTHERAPY ALONE OR COMBINED WITH NEUROSURGERY
    VECHT, CJ
    HAAXMAREICHE, H
    NOORDIJK, EM
    PADBERG, GW
    VOORMOLEN, JHC
    HOEKSTRA, FH
    TANS, JTJ
    LAMBOOIJ, N
    METSAARS, JAL
    WATTENDORFF, AR
    BRAND, R
    HERMANS, J
    [J]. ANNALS OF NEUROLOGY, 1993, 33 (06) : 583 - 590
  • [23] DOSE-RESPONSE RELATIONSHIP FOR RADIATION-THERAPY OF SUBCLINICAL DISEASE
    WITHERS, HR
    PETERS, LJ
    TAYLOR, JMG
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (02): : 353 - 359
  • [24] YUH WTC, 1992, AM J NEURORADIOL, V13, P335